Blog

Drew Moghanaki: The future of radiation therapy is bright indeed

Drew Moghanaki/uclahealth.org

Jan 8, 2025, 10:09

Drew Moghanaki: The future of radiation therapy is bright indeed

Drew Moghanaki, Professor and Chief of Thoracic Oncology at the Department of Radiation Oncology, UCLA, shared a post on X by Albert Koong, Division Head and Chair of Radiation Oncology at MD Anderson Cancer Center, adding:

“Impressive agenda of scientific lectures. The future of radiation therapy is bright indeed.”

Quoting Albert Koong’s post:

“Join us for the AACR Special Conference on Translating Radiation and Targeted Therapy Combinations, Jan 26-29. Keynote addresses by Michael Baumann and Ralph Weichselbaum.”

More posts featuring Drew Moghanaki and Albert Koong.

Drew Moghanaki is a Professor and Chief of Thoracic Oncology at the Department of Radiation Oncology, UCLA. He holds the Stanley Iezman and Nancy Stark Endowed Chair in Thoracic Radiation Oncology Research at the same university.

He specializes in treating lung cancer and other thoracic malignancies, focusing on advanced radiation therapy techniques like stereotactic body radiation therapy (SBRT), magnetic resonance-guided radiation therapy (MRgRT), and intensity-modulated radiation therapy (IMRT).

Albert C. Koong is the Division Head and Chair of Radiation Oncology at MD Anderson Cancer Center, holding the Olga Keith and Harry Carothers Wiess Distinguished University Chair.

A Fellow of the American College of Radiology (FACR) and ASTRO (FASTRO), his clinical research focuses on advanced radiotherapy techniques, including SBRT/SABR, for gastrointestinal cancers such as pancreatic and liver cancer.

His NIH/NCI-funded laboratory investigates endoplasmic reticulum stress in tumor growth and metastasis, with a focus on developing targeted therapies and predictive biomarkers.